158 related articles for article (PubMed ID: 21035398)
1. Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy.
Sanli H; Akay BN; Ayyildiz E; Anadolu R; Ilhan O
Transfus Apher Sci; 2010 Dec; 43(3):353-359. PubMed ID: 21035398
[TBL] [Abstract][Full Text] [Related]
2. Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases.
Wollina U; Lange D; Looks A
Dermatology; 1999; 198(2):140-4. PubMed ID: 10325460
[TBL] [Abstract][Full Text] [Related]
3. Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy.
Miller JL; Stricklin GP; Fine JD; King LE; Arzubiaga MC; Ellis DL
Br J Dermatol; 1995 Sep; 133(3):467-71. PubMed ID: 8547007
[TBL] [Abstract][Full Text] [Related]
4. Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy.
Gordon KB; Chan LS; Woodley DT
Br J Dermatol; 1997 Mar; 136(3):415-20. PubMed ID: 9115929
[TBL] [Abstract][Full Text] [Related]
5. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis for the treatment of autoimmune diseases.
Adamski J; Kinard T; Ipe T; Cooling L
Transfus Apher Sci; 2015 Apr; 52(2):171-82. PubMed ID: 25886694
[TBL] [Abstract][Full Text] [Related]
7. The successful use of extracorporeal photopheresis in a 12-year-old patient with refractory epidermolysis bullosa acquisita.
Liszewski W; Omland SH; Gniadecki R
Pediatr Dermatol; 2015; 32(2):e60-1. PubMed ID: 25639865
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in the treatment of epidermolysis bullosa acquisita.
Gürcan HM; Ahmed AR
Expert Opin Pharmacother; 2011 Jun; 12(8):1259-68. PubMed ID: 21254861
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune bullous diseases: diagnosis and management.
McCuin JB; Hanlon T; Mutasim DF
Dermatol Nurs; 2006 Feb; 18(1):20-5. PubMed ID: 16550892
[TBL] [Abstract][Full Text] [Related]
10. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases.
Harman KE; Black MM
Br J Dermatol; 1999 May; 140(5):865-74. PubMed ID: 10354024
[TBL] [Abstract][Full Text] [Related]
11. Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Andreu-Ullrich H
Transfus Apher Sci; 2014 Jun; 50(3):363-9. PubMed ID: 24816437
[TBL] [Abstract][Full Text] [Related]
12. Drug-resistant bullous pemphigoid and inflammatory bowel disease in a pediatric case successfully treated by plasma exchange and extracorporeal photochemotherapy.
Tripodi G; Risso M; Tenerini L; Gandullia P; Castellano E; Rivabella L
J Clin Apher; 2007 Feb; 22(1):26-30. PubMed ID: 17285616
[TBL] [Abstract][Full Text] [Related]
13. [Resistant acquired bullous epidermolysis with severe ocular involvement: the success of extracorporeal photochemotherapy].
Camara A; Bécherel PA; Bussel A; Lagrange S; Chosidow O; Joly P; Piette JC; Francès C
Ann Dermatol Venereol; 1999; 126(8-9):612-5. PubMed ID: 10530350
[TBL] [Abstract][Full Text] [Related]
14. Emerging treatment for epidermolysis bullosa acquisita.
Engineer L; Ahmed AR
J Am Acad Dermatol; 2001 May; 44(5):818-28. PubMed ID: 11312431
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita.
Kofler H; Wambacher-Gasser B; Topar G; Weinlich G; Schuler G; Hintner H; Romani N; Fritsch P
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 2):331-5. PubMed ID: 9039213
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
Hashimoto T; Ishii N; Ohata C; Furumura M
J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune blistering skin diseases.
Cotell S; Robinson ND; Chan LS
Am J Emerg Med; 2000 May; 18(3):288-99. PubMed ID: 10830686
[TBL] [Abstract][Full Text] [Related]
18. Expression of the alpha 6 beta 4 integrin in lesional skin differentiates bullous pemphigoid (BP) from epidermolysis bullosa acquisita (EBA).
Michalaki H; Staquet MJ; Cerri A; Berti E; Roche P; Machado P; Nicolas JF
J Invest Dermatol; 1992 Feb; 98(2):204-8. PubMed ID: 1732384
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris.
Behzad M; Möbs C; Kneisel A; Möller M; Hoyer J; Hertl M; Eming R
Br J Dermatol; 2012 Apr; 166(4):844-52. PubMed ID: 22092243
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita.
Endo Y; Tamura A; Ishikawa O; Miyachi Y; Hashimoto T
Br J Dermatol; 1997 Nov; 137(5):783-6. PubMed ID: 9415242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
